English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Generation of two human isogenic iPSC lines from fetal dermal fibroblasts

MPS-Authors
/persons/resource/persons232003

Brändl,  Björn
Dept. of Genome Regulation (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons208936

Landshammer,  Alexandro
Dept. of Genome Regulation (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons220217

Müller,  Franz-Josef
Cellular Phenotyping (Franz-Josef Müller), Dept. of Genome Regulation, (Head: Alexander Meissner), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

Tandon.pdf
(Publisher version), 2MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Tandon, R., Brändl, B., Baryshnikova, N., Landshammer, A., Steenpaß, L., Keminer, O., et al. (2018). Generation of two human isogenic iPSC lines from fetal dermal fibroblasts. Stem Cell Research, 33, 120-124. doi:10.1016/j.scr.2018.10.004.


Cite as: http://hdl.handle.net/21.11116/0000-0003-5810-8
Abstract
Two isogenic hiPSC lines, ZIPi013-B and ZIPi013-E, were generated by reprogramming fetal dermal fibroblasts with episomal vectors. Previously, the same fetal fibroblasts were reprogrammed multiple times in a study comparing other reprogramming methods. As a consequence, the genomes have been sequenced multiple times. Both new cell lines offer the opportunity to study basic stem cell biology and model human disease. They can be applied as reference cell lines for creating isogenic clones bearing disease mutations on a well-characterized genomic background, as both cell lines have demonstrated excellent differentiation capacity in multiple labs.